Prescription Drug Prices Caused Walmart's Sales Miss

Earnings
โดย 24/7 Wall St.·US·Read original
Summary · why it matters

Falling prescription drug prices dragged Walmart's U.S. comparable sales down 80 to 90 basis points, masking what would otherwise have been roughly 3.4% growth. Target's 3.8% comparable sales outpaced Walmart's 2.6% because it sold its pharmacy business to CVS for $1.9 billion in 2015, sidestepping drug-price deflation entirely. Walmart's transaction growth slowed to 1.5% from 3%, signaling lower-income shoppers are making fewer trips even as higher-income consumers trade down to Walmart.

Impact on stocks 4

Consumer Staples± Mixed · 2 stocks
Walmart Inc.
WMT
▼ NegativePricingrelevance

Falling prescription drug prices dragged Walmart's comparable sales down 80-90 bps.

Target Corporation
TGT
▲ PositiveCapitalrelevance

Target's sale of pharmacy business to CVS in 2015 helps it avoid drug-price deflation, boosting comparable sales.

Health Care▲ · 2 stocks
CVS Health Corp
CVS
▲ PositiveDemandrelevance

CVS benefits from Target's pharmacy business sale, avoiding drug-price deflation.

© 2026 MarketDXNews